BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18390462)

  • 1. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
    Potter KL; Held-Warmkessel J
    Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
    Marin K; Oleszewski K; Muehlbauer P
    Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.
    Anderson NJ; Hacker ED
    Clin J Oncol Nurs; 2008 Jun; 12(3):445-54. PubMed ID: 18515243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment.
    Muggia FM
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S18-24. PubMed ID: 17223446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer.
    Sun V; Otis-Green S; Morgan R; Wakabayashi M; Hakim A; Callado ME; Yang E; Ferrell B; Grant M
    Eur J Oncol Nurs; 2013 Jun; 17(3):375-80. PubMed ID: 23153453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments.
    Kyrgiou M; Salanti G; Pavlidis N; Paraskevaidis E; Ioannidis JP
    J Natl Cancer Inst; 2006 Nov; 98(22):1655-63. PubMed ID: 17105988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
    Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
    Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
    Naumann RW; Sukumvanich P; Edwards RP
    Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy supporting the role of intraperitoneal drug delivery in the primary chemotherapeutic management of small-volume residual advanced ovarian cancer.
    Markman M
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S3-7. PubMed ID: 17223444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ovarian cancer with intraperitoneal chemotherapy.
    Hydzik C
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):15-20. PubMed ID: 19856603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
    Chin SN; Pinto V; Rosen B; Oza A; Dodge J; Murphy J; Mackay H
    Gynecol Oncol; 2009 Mar; 112(3):450-4. PubMed ID: 19135709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal chemotherapy for ovarian cancer.
    Hamilton CA; Berek JS
    Curr Opin Oncol; 2006 Sep; 18(5):507-15. PubMed ID: 16894301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of women with newly diagnosed ovarian cancer.
    Krasner C; Duska L
    Semin Oncol; 2009 Apr; 36(2):91-105. PubMed ID: 19332244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing the delivery of intraperitoneal therapy while minimizing drug toxicity and maintaining quality of life.
    Alberts DS; Delforge A
    Semin Oncol; 2006 Dec; 33(6 Suppl 12):S8-17. PubMed ID: 17223445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.